Literature DB >> 16847181

Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma.

Mamoru Yoshikawa1, Hiromi Kojima, Kota Wada, Toshiharu Tsukidate, Naoko Okada, Hirohisa Saito, Hiroshi Moriyama.   

Abstract

OBJECTIVE: To investigate the role of fibroblasts in the pathogenesis of cholesteatoma.
DESIGN: Tissue specimens were obtained from our patients. Middle ear cholesteatoma-derived fibroblasts (MECFs) and postauricular skin-derived fibroblasts (SFs) as controls were then cultured for a few weeks. These fibroblasts were stimulated with interleukin (IL) 1alpha and/or IL-1beta before gene expression assays. We used the human genome U133A probe array (GeneChip) and real-time polymerase chain reaction to examine and compare the gene expression profiles of the MECFs and SFs.
SUBJECTS: Six patients who had undergone tympanoplasty.
RESULTS: The IL-1alpha-regulated genes were classified into 4 distinct clusters on the basis of profiles differentially regulated by SF and MECF using a hierarchical clustering analysis. The messenger RNA expressions of LARC (liver and activation-regulated chemokine), GMCSF (granulocyte-macrophage colony-stimulating factor), epiregulin, ICAM1 (intercellular adhesion molecule 1), and TGFA (transforming growth factor alpha) were more strongly up-regulated by IL-1alpha and/or IL-1beta in MECF than in SF, suggesting that these fibroblasts derived from different tissues retained their typical gene expression profiles.
CONCLUSIONS: Fibroblasts may play a role in hyperkeratosis of middle ear cholesteatoma by releasing molecules involved in inflammation and epidermal growth. These fibroblasts may retain tissue-specific characteristics presumably controlled by epigenetic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847181     DOI: 10.1001/archotol.132.7.734

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21.

Authors:  David R Friedland; Rebecca Eernisse; Christy Erbe; Nidhi Gupta; Joseph A Cioffi
Journal:  Otol Neurotol       Date:  2009-10       Impact factor: 2.311

2.  Intercellular Communication between Keratinocytes and Fibroblasts Induces Local Osteoclast Differentiation: a Mechanism Underlying Cholesteatoma-Induced Bone Destruction.

Authors:  Yoriko Iwamoto; Keizo Nishikawa; Ryusuke Imai; Masayuki Furuya; Maki Uenaka; Yumi Ohta; Tetsuo Morihana; Saori Itoi-Ochi; Josef M Penninger; Ichiro Katayama; Hidenori Inohara; Masaru Ishii
Journal:  Mol Cell Biol       Date:  2016-05-16       Impact factor: 4.272

3.  Cholesteatoma fibroblasts promote epithelial cell proliferation through overexpression of epiregulin.

Authors:  Mamoru Yoshikawa; Hiromi Kojima; Yuichiro Yaguchi; Naoko Okada; Hirohisa Saito; Hiroshi Moriyama
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

4.  Interaction between IRF6 and TGFA genes contribute to the risk of nonsyndromic cleft lip/palate.

Authors:  Ariadne Letra; Walid Fakhouri; Renata F Fonseca; Renato Menezes; Inga Kempa; Joanne L Prasad; Toby G McHenry; Andrew C Lidral; Lina Moreno; Jeffrey C Murray; Sandra Daack-Hirsch; Mary L Marazita; Eduardo E Castilla; Baiba Lace; Ieda M Orioli; Jose M Granjeiro; Brian C Schutte; Alexandre R Vieira
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

5.  Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.

Authors:  Kuen Yao Ho; Tai Sheng Yeh; Han Hsiang Huang; Kuo Feng Hung; Chee Yin Chai; Wan Tzu Chen; Shih Meng Tsai; Ning Chia Chang; Chen Yu Chien; Hsun Mo Wang; Yu Jen Wu
Journal:  Int J Mol Sci       Date:  2013-07-11       Impact factor: 5.923

6.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

Review 7.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

8.  Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays.

Authors:  Christin Klenke; Sebastian Janowski; Daniela Borck; Darius Widera; Jörg Ebmeyer; Jörn Kalinowski; Anke Leichtle; Ralf Hofestädt; Tahwinder Upile; Christian Kaltschmidt; Barbara Kaltschmidt; Holger Sudhoff
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.